BackConnect Biopharma Holdings Overview
Connect Biopharma Holdings Ltd - ADR

Connect Biopharma Holdings Target Price

Where could CNTB trade next? Consensus target price: $7.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.67

Average Target Price

$7.00952.2% upside

1 analysts in the last 4 months

High: $7 | Low: $7

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-14Canaccord GenuityEdward Nash$7952.2% upsideOpen
2026-07-09Oppenheimer$81102.5% upsideOpen
2026-06-26Piper Sandler$7952.2% upsideOpen
2026-06-18H.C. WainwrightBrandon Folkes$7952.2% upsideOpen
2026-05-26Canaccord GenuityEdward Nash$6801.8% upsideOpen
2026-05-21Cantor FitzgeraldOlivia Brayer$4501.2% upsideOpen
2025-12-01Lake StreetThomas Flaten$91252.8% upsideOpen
2022-05-05Piper SandlerJoseph Catanzaro$1.5125.5% upsideOpen

Connect Biopharma Holdings (CNTB) FAQ

The latest target price for CNTB is $7. Investors often review this figure alongside Connect Biopharma Holdings's historical trend and sector peers before judging valuation or financial health.

Connect Biopharma Holdings trades near $0.67 while the consensus target sits at $7 (952.2% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting CNTB's target price ($7), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Connect Biopharma Holdings's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.